Search

everythinglearnresearchcommunity

for

Search:↓

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.

Certain gene variations in PITX2 are linked to a higher risk of male pattern baldness in Indians.

Tofacitinib is an effective and safe treatment for alopecia areata.

Certain metabolites can either protect against or increase the risk of hair loss.

Male pattern baldness does not cause an increased risk of prostate cancer.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

People with non-scarring hair loss often have lower vitamin D levels than those without hair loss.

Many pediatric epilepsy patients experience preventable severe adverse drug reactions, especially with certain medications and risk factors.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

PRP is effective for treating hair loss, improving hair density, count, and thickness.